Thomas T. Yoshikawa, Shobita Rajagopalan

• Epidemiology and Unique Aspects of Infections. Clinical Manifestations of Infections. Host Resistance. Functional Assessment. Nutritional Assessment and Intervention. Pharmacology. Penicillins. Cephalosporins. Carbapenems. Monobactams. Beta-lactamase Inhibitors. Glycopeptides. Quinolones. Aminoglycosides. Tetracyclines.. Mcarolides/Ketolides. Clindamycin. Metronidazole. Chloramphenicol. Trimethoprim-sulfamethoxazole. Nitrofurans. Streptogrammins. Linezolids. Antiuberculous Drugs. Antiviral Drugs. Antifungal Drugs. Antiparasitic Drugs. Eye Infections. Oral Infections. Sinus and Ear Infections. Respiratory Infections. Tuberculosis. Intraabdominal Infections. Viral Hepatitis. Urinary Tract Infections. Skin and Soft Tissue Infections. Herpes Zoster. Bacterial Meningitis.Infective Endocarditis. Bone and Joint Infections. Prosthetic Device Infections. Human Immunodeficiency Virus Infection. Septic Shock. Bacteria. Fungi. Viruses. Parasites. New and Emerging Pathogens. Unique Aspects of Nursing Home Setting. Common Infections. Infection Control

Thomas T. Yoshikawa, Shobita Rajagopalan

• Epidemiology and Unique Aspects of Infections. Clinical Manifestations of Infections. Host Resistance. Functional Assessment. Nutritional Assessment and Intervention. Pharmacology. Penicillins. Cephalosporins. Carbapenems. Monobactams. Beta-lactamase Inhibitors. Glycopeptides. Quinolones. Aminoglycosides. Tetracyclines.. Mcarolides/Ketolides. Clindamycin. Metronidazole. Chloramphenicol. Trimethoprim-sulfamethoxazole. Nitrofurans. Streptogrammins. Linezolids. Antiuberculous Drugs. Antiviral Drugs. Antifungal Drugs. Antiparasitic Drugs. Eye Infections. Oral Infections. Sinus and Ear Infections. Respiratory Infections. Tuberculosis. Intraabdominal Infections. Viral Hepatitis. Urinary Tract Infections. Skin and Soft Tissue Infections. Herpes Zoster. Bacterial Meningitis.Infective Endocarditis. Bone and Joint Infections. Prosthetic Device Infections. Human Immunodeficiency Virus Infection. Septic Shock. Bacteria. Fungi. Viruses. Parasites. New and Emerging Pathogens. Unique Aspects of Nursing Home Setting. Common Infections. Infection Control

Thomas T. Yoshikawa, Shobita Rajagopalan

• Epidemiology and Unique Aspects of Infections. Clinical Manifestations of Infections. Host Resistance. Functional Assessment. Nutritional Assessment and Intervention. Pharmacology. Penicillins. Cephalosporins. Carbapenems. Monobactams. Beta-lactamase Inhibitors. Glycopeptides. Quinolones. Aminoglycosides. Tetracyclines.. Mcarolides/Ketolides. Clindamycin. Metronidazole. Chloramphenicol. Trimethoprim-sulfamethoxazole. Nitrofurans. Streptogrammins. Linezolids. Antiuberculous Drugs. Antiviral Drugs. Antifungal Drugs. Antiparasitic Drugs. Eye Infections. Oral Infections. Sinus and Ear Infections. Respiratory Infections. Tuberculosis. Intraabdominal Infections. Viral Hepatitis. Urinary Tract Infections. Skin and Soft Tissue Infections. Herpes Zoster. Bacterial Meningitis.Infective Endocarditis. Bone and Joint Infections. Prosthetic Device Infections. Human Immunodeficiency Virus Infection. Septic Shock. Bacteria. Fungi. Viruses. Parasites. New and Emerging Pathogens. Unique Aspects of Nursing Home Setting. Common Infections. Infection Control